Tenet Healthcare Corp income statement THC

In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, Tenet Healthcare Corp reported revenue of $5.6 billion, up 6.5% from the same quarter a year earlier. Net income was $1.2 billion, a profit margin of 21.6%. Operating income came to $1.8 billion, an operating margin of 31.1%. Diluted earnings per share were $12.41.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.

Line
TTM
Sep 30, 2026
Q3 FY2026
Sep 30, 2026
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Q1 FY2025
Mar 31, 2025
Q4 FY2024
Dec 31, 2024
Revenue
22,154
+6.2%
5,631
+6.5%
5,628
+6.8%
5,368
+2.8%
5,527
+8.9%
5,289
+3.2%
5,271
+3.2%
5,223
-2.7%
5,073
-6.0%
Operating income
5,400
+55.4%
1,750
+96.9%
1,501
+82.4%
1,296
+37.4%
853
+3.9%
889
-18.4%
823
+8.1%
943
-71.3%
821
+11.7%
Pretax income
—
—
1,340
+108.7%
1,132
+48.0%
681
+4.0%
712
-22.8%
642
+9.4%
765
-75.2%
655
+26.2%
Income tax
918
+91.6%
360
+170.7%
295
+145.8%
226
+58.0%
37
-55.4%
133
-44.8%
120
+9.1%
143
-80.9%
83
+31.7%
Net income
3,814
+66.2%
1,219
+110.5%
1,045
+100.2%
906
+45.7%
644
+12.6%
579
-15.0%
522
+9.4%
622
-73.4%
572
+25.4%
Net income to common
2,899
+114.1%
1,000
+192.4%
826
+186.8%
702
+72.9%
371
+16.7%
342
-27.5%
288
+11.2%
406
-81.1%
318
+30.3%
Basic EPS
34.33
+133.5%
12.48
+220.8%
9.89
+213.0%
8.09
+87.7%
4.25
+27.1%
3.89
-21.1%
3.16
+18.8%
4.31
-80.0%
3.34
+38.3%
Diluted EPS
34.09
+133.8%
12.41
+221.5%
9.84
+213.4%
8.01
+87.6%
4.22
+27.3%
3.86
-21.1%
3.14
+18.9%
4.27
-80.0%
3.31
+41.4%
Weighted average shares, basic
84
-8.3%
80
-8.9%
84
-8.4%
87
-7.9%
87
-8.2%
88
-8.1%
91
-6.3%
94
-5.4%
95
-5.8%
Weighted average shares, diluted
85
-8.4%
81
-9.0%
84
-8.5%
88
-7.8%
88
-8.4%
89
-8.3%
92
-6.8%
95
-5.5%
96
-7.8%
Other measures
Depreciation and amortization
892
+8.1%
217
-0.5%
215
+3.4%
229
+11.2%
231
+19.7%
218
+4.3%
208
+0.0%
206
-1.0%
193
-10.6%
EBITDA
6,292
+46.3%
1,967
+77.7%
1,716
+66.4%
1,525
+32.7%
1,084
+6.9%
1,107
-14.7%
1,031
+6.4%
1,149
-67.1%
1,014
+6.6%
Interest coverage
6.61x
8.62x
7.36x
6.32x
4.16x
4.32x
4.00x
4.62x
4.04x
Margins
Operating margin
24.37%
31.08%
26.67%
24.14%
15.43%
16.81%
15.61%
18.05%
16.18%
Pretax margin
—
—
23.81%
21.09%
12.32%
13.46%
12.18%
14.65%
12.91%
Profit margin
17.22%
21.65%
18.57%
16.88%
11.65%
10.95%
9.90%
11.91%
11.28%
EBITDA margin
28.40%
34.93%
30.49%
28.41%
19.61%
20.93%
19.56%
22.00%
19.99%
Effective tax rate
—
—
22.01%
19.96%
5.43%
18.68%
18.69%
18.69%
12.67%
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Services-General Medical & Surgical Hospitals, NEC (SIC 8062)
Listed as
THC (NYSE)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Dallas, TX
SEC filer status
Large accelerated filer
SEC CIK
70318
Former names
NATIONAL MEDICAL ENTERPRISES INC /NV/ (until Mar 27, 1995)

Other Services-General Medical & Surgical Hospitals, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.